BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22164556)

  • 1. An incremental economic evaluation of targeted and universal influenza vaccination in pregnant women.
    Skedgel C; Langley JM; MacDonald NE; Scott J; McNeil S
    Can J Public Health; 2011; 102(6):445-50. PubMed ID: 22164556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of universal influenza vaccination in a pregnant population.
    Roberts S; Hollier LM; Sheffield J; Laibl V; Wendel GD
    Obstet Gynecol; 2006 Jun; 107(6):1323-9. PubMed ID: 16738159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of influenza vaccination during pregnancy in Japan.
    Hoshi SL; Shono A; Seposo X; Okubo I; Kondo M
    Vaccine; 2020 Oct; 38(46):7363-7371. PubMed ID: 33020012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Web-based intervention for improving influenza vaccination in pregnant women: a cost-effectiveness analysis.
    Wang Y; Fekadu G; You JHS
    Pathog Glob Health; 2024 Mar; 118(2):99-108. PubMed ID: 37846153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department.
    Hart RJ; Stevenson MD; Smith MJ; LaJoie AS; Cross K
    JAMA Pediatr; 2018 Jan; 172(1):e173879. PubMed ID: 29114729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of seasonal inactivated influenza vaccination among pregnant women.
    Xu J; Zhou F; Reed C; Chaves SS; Messonnier M; Kim IK
    Vaccine; 2016 Jun; 34(27):3149-3155. PubMed ID: 27161997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands.
    de Boer PT; Nagy L; Dolk FCK; Wilschut JC; Pitman R; Postma MJ
    Value Health; 2021 Jan; 24(1):19-31. PubMed ID: 33431149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of seasonal influenza vaccination in pregnant women, healthcare workers and adults >= 60 years of age in Lao People's Democratic Republic.
    Ortega-Sanchez IR; Mott JA; Kittikraisak W; Khanthamaly V; McCarron M; Keokhonenang S; Ounaphom P; Pathammavong C; Phounphenghack K; Sayamoungkhoun P; Chanthavilay P; Bresee J; Tengbriacheu C
    Vaccine; 2021 Dec; 39(52):7633-7645. PubMed ID: 34802790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany.
    Scholz SM; Weidemann F; Damm O; Ultsch B; Greiner W; Wichmann O
    Value Health; 2021 Jan; 24(1):32-40. PubMed ID: 33431151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost-effectiveness of vaccinating pregnant women against pandemic influenza in Colombia].
    Chocontá-Piraquive LA; Alvis Guzmán N; De la Hoz Restrepo F
    Rev Panam Salud Publica; 2012 Jun; 31(6):447-53. PubMed ID: 22858810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of timing of seasonal influenza vaccination on effectiveness and cost-effectiveness in pregnancy.
    Myers ER; Misurski DA; Swamy GK
    Am J Obstet Gynecol; 2011 Jun; 204(6 Suppl 1):S128-40. PubMed ID: 21640230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
    Rothberg MB; Rose DN
    Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of inactivated influenza vaccination in children with medical risk conditions in the Netherlands.
    Naber SK; Bruijning-Verhagen PCJL; de Hoog MLA; van Giessen A
    Vaccine; 2020 Apr; 38(17):3387-3396. PubMed ID: 32115297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysis.
    Brydak L; Roiz J; Faivre P; Reygrobellet C
    Clin Drug Investig; 2012 Feb; 32(2):73-85. PubMed ID: 22201294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programme costs for introducing age/gestation-based universal influenza vaccine schedules for young children and pregnant women in Hong Kong.
    de Haas TDJ; Yeung KHT; Hutubessy R; van der Putten IM; Nelson EAS
    Vaccine; 2021 Nov; 39(46):6762-6780. PubMed ID: 34743828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model.
    Aballéa S; Chancellor J; Martin M; Wutzler P; Carrat F; Gasparini R; Toniolo-Neto J; Drummond M; Weinstein M
    Value Health; 2007; 10(2):98-116. PubMed ID: 17391419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany.
    Damm O; Eichner M; Rose MA; Knuf M; Wutzler P; Liese JG; Krüger H; Greiner W
    Eur J Health Econ; 2015 Jun; 16(5):471-88. PubMed ID: 24859492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic value of seasonal and pandemic influenza vaccination during pregnancy.
    Beigi RH; Wiringa AE; Bailey RR; Assi TM; Lee BY
    Clin Infect Dis; 2009 Dec; 49(12):1784-92. PubMed ID: 19911967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales.
    Jit M; Cromer D; Baguelin M; Stowe J; Andrews N; Miller E
    Vaccine; 2010 Dec; 29(1):115-22. PubMed ID: 21055501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States.
    Clements KM; Meier G; McGarry LJ; Pruttivarasin N; Misurski DA
    Hum Vaccin Immunother; 2014; 10(5):1171-80. PubMed ID: 24609063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.